RA
DVAX

Rise Advisors’s Dynavax Technologies DVAX Stock Holding History

Rise Advisors’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,252
Closed -$22.4K – 489
2025
Q3 		$22.4K Buy
2,252
+46
+2% +$479 0.01% 517
2025
Q2 		$21.9K Hold
2,206
– – 0.01% 480
2025
Q1 		$28.6K Buy
2,206
+749
+51% +$9.91K 0.01% 337
2024
Q4 		$18.6K Hold
1,457
– – 0.01% 711
2024
Q3 		$16.2K Hold
1,457
– – 0.01% 827
2024
Q2 		$16.4K Hold
1,457
– – 0.01% 775
2024
Q1 		$18.1K Hold
1,457
– – 0.01% 713
2023
Q4 		$20.4K Hold
1,457
– – 0.01% 249
2023
Q3 		$21.5K Buy
+1,457
New +$20.5K 0.02% 224

Other funds holding DVAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Rise Advisors's DVAX Position: Q4 2025 in Review

Rise Advisors sold out of Dynavax Technologies (DVAX) in Q4 2025, closing a stake of 2,252 shares — an estimated $22.4K sold.

Rise Advisors first reported a position in DVAX in Q3 2023 and held it in 9 quarters. The position peaked at $28.6K in Q1 2025. 266 funds tracked by Wall St. Rank hold DVAX as of Q4 2025.

  • Rise Advisors reported no remaining Dynavax Technologies position as of Q4 2025 after selling out during the quarter.
  • Rise Advisors sold 2,252 Dynavax Technologies shares in Q4 2025, an estimated $22.4K.
  • Rise Advisors first reported a position in Dynavax Technologies in Q3 2023 and held it in 9 quarters.
  • Rise Advisors's Dynavax Technologies position peaked at $28.6K in Q1 2025.
  • 266 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.